The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
-
* Corresponding author: Atle Fretheim atle.fretheim@shdir.no
BMC Health Services Research 2003, 3:18 doi:10.1186/1472-6963-3-18
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 30 Apr 2003 | |
| Reviewer's Report | Mark Nelson | 09 May 2003 | |
| Reviewer's Report | Gilbert L'Italien | 10 Jun 2003 | |
| Reviewer's Report | James Wright | 16 Jun 2003 | |
| Reviewer's Report | David Henry | 01 Jul 2003 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 10 Jul 2003 |
| Reviewer's Report | David Henry | 29 Jul 2003 | |
| Reviewer's Report | James Wright | 05 Aug 2003 | |
| Reviewer's Report | Gilbert L'Italien | 08 Aug 2003 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 21 Aug 2003 |
| Published | 08 Sep 2003 |